Two-week break in methotrexate treatment and COVID-19 vaccine response: a prospective, open label, two-arm parallel-group, multicentre, superiority, randomised controlled trial

Abhishek, Abhishek; Peckham, Nicholas; Pade, Corinna; Gibbons, Joseph M.; Cureton, Lucy; Francis, Anne; Barber, Vicki; Williams, Jennifer A. E.; Appelbe, Duncan; Eldridge, Lucy; Julier, Patrick; Altmann, Daniel M.; Bluett, James; Brooks, Tim; Coates, Laura C.; Rombach, Ines; Semper, Amanda; Otter, Ashley; Valdes, Ana M.; Nguyen-Van-Tam, Jonathan S.; Williams, Hywel C.; Boyton, Rosemary J.; McKnight, Áine; Cook, Jonathan A.; Study investigators, VROOM

All Outputs (2)

Uptake and safety of pneumococcal vaccination in adults with immune mediated inflammatory diseases: a UK wide observational study (2024)
Journal Article
Nakafero, G., Grainge, M. J., Card, T., Mallen, C. D., Nguyen Van-Tam, J. S., Abhishek, A., & . (2024). Uptake and safety of pneumococcal vaccination in adults with immune mediated inflammatory diseases: a UK wide observational study. Rheumatology, Article keae160. https://doi.org/10.1093/rheumatology/keae160

Objective The uptake and safety of pneumococcal vaccination in people with immune mediated inflammatory diseases (IMIDs) is poorly understood. We investigated the UK wide pneumococcal vaccine uptake in adults with IMIDs and explored the association b... Read More about Uptake and safety of pneumococcal vaccination in adults with immune mediated inflammatory diseases: a UK wide observational study.

Two-week break in methotrexate treatment and COVID-19 vaccine response: a prospective, open label, two-arm parallel-group, multicentre, superiority, randomised controlled trial (2023)
Journal Article
Abhishek, A., Peckham, N., Pade, C., Gibbons, J. M., Cureton, L., Francis, A., …Study investigators, V. (in press). Two-week break in methotrexate treatment and COVID-19 vaccine response: a prospective, open label, two-arm parallel-group, multicentre, superiority, randomised controlled trial. The Lancet Rheumatology,